Cargando…

Interaction between renal function and the effect of levosimendan on long-term mortality of patients with low-output heart failure

Detalles Bibliográficos
Autores principales:	Cleland, J, Nieminen, M, Kivikko, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301502/ http://dx.doi.org/10.1186/cc1946

Ejemplares similares

Effect of β-blockade on the haemodynamic responses of levosimendan and dobutamine in the treatment of low-output heart failure
por: Follath, F, et al.
Publicado: (2002)

Study design of a mortality trial with intravenous levosimendan (the SURVIVE study) in patients with acutely decompensated heart failure
por: Mebazaa, A, et al.
Publicado: (2004)

Effects of levosimendan on cardiac arrhythmia in patients with severe heart failure
por: Lilleberg, J, et al.
Publicado: (2002)

Levosimendan improves hemodynamic effects in patients with acutely decompensated heart failure: the Argentinean multicenter registry
por: Perrone, SV, et al.
Publicado: (2003)

Repetitive levosimendan treatment in the management of advanced heart failure
por: Oliva, Fabrizio, et al.
Publicado: (2018)

Hemodynamic effects of levosimendan in patients with low-output heart failure
por: Gharsallah, H, et al.
Publicado: (2008)

Levosimendan treatment for acutely decompensated heart failure is as effective for Chagas disease patients as for patients with other etiologies
por: Pereira-Barretto, AC, et al.
Publicado: (2003)

Levosimendan benefits critically ill patients with decompensated heart failure assessed with plasma B-type natriuretic peptide (BNP) and LVEF
por: McLean, AS, et al.
Publicado: (2003)

Myocardial efficiency during levosimendan infusion
por: Voipio-Pulkki, L-M, et al.
Publicado: (2002)

Levosimendan: current data, clinical use and future development
por: Nieminen, M S, et al.
Publicado: (2013)

Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers
por: Bergh, Claes-Håkan, et al.
Publicado: (2010)

Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application
por: Bouchez, S., et al.
Publicado: (2018)

The potential of the inodilator levosimendan in maintaining quality of life in advanced heart failure
por: Nieminen, Markku S., et al.
Publicado: (2017)

Hemodynamic effects of levosimendan after surgery in LPS pretreated rabbits
por: Faivre, V, et al.
Publicado: (2003)

Levosimendan in Acute and Advanced Heart Failure: An Appraisal of the Clinical Database and Evaluation of Its Therapeutic Applications
por: Altenberger, Johann, et al.
Publicado: (2018)

Haemodynamic effects of levosimendan in patients during weaning from cardiopulmonary bypass
por: Demeyere, R, et al.
Publicado: (2002)

ICU acquired acute renal failure carries a higher mortality than acute renal failure on admission to ICU
por: Ostermann, M, et al.
Publicado: (2001)

Levosimendan enhances cardiac performance in patients following cardiac surgery and cardiopulmonary bypass
por: Sandell, E-P, et al.
Publicado: (2002)

Levosimendan preconditioning in patients undergoing elective cardiac surgery with poor ejection fraction. preliminary results.
por: Ávalos, R, et al.
Publicado: (2015)

Monitoring cardiac output in beating heart coronary artery bypass graft surgery: use of pulse contour cardiac output
por: Chan, TML, et al.
Publicado: (2001)

Use of levosimendan in acute heart failure
por: Harjola, Veli-Pekka, et al.
Publicado: (2018)

Factors affecting mortality from acute renal failure in the ICU
por: Ostermann, ME, et al.
Publicado: (2002)

Mortality reduction with levosimendan in patients with heart failure: Current evidence is underpowered
por: Sanfilippo, Filippo, et al.
Publicado: (2021)

The effects of levosimendan on myocardial oxygen consumption and coronary blood flow early after coronary artery bypass grafting
por: Lilleberg, J, et al.
Publicado: (2002)

Low urine output in acute renal dysfunction (ARI/ARFS) diagnosis
por: Sramek, V, et al.
Publicado: (2002)

Shock, acute renal failure and MODS as mortality indicator in acute pancreatitis
por: Segura, V, et al.
Publicado: (2001)

Renal Effects of Levosimendan: A Consensus Report
por: Yilmaz, Mehmet B., et al.
Publicado: (2013)

A review of levosimendan in the treatment of heart failure
por: Kasikcioglu, Hulya Akhan, et al.
Publicado: (2006)

Levosimendan in pulmonary hypertension and right heart failure
por: Hansen, Mona Sahlholdt, et al.
Publicado: (2018)

Use of Levosimendan in Patients with Advanced Heart Failure: An Update
por: Masarone, Daniele, et al.
Publicado: (2022)

Incidence and course of early cardiac failure in long term ICU patients
por: Sramek, V, et al.
Publicado: (2001)

Urine output in the first twelve hours after cardiopulmonary bypass does not predict the development of renal impairment
por: Ali, SM, et al.
Publicado: (1999)

P01-035 – Long-term IV colchicine in oral colchicines failure
por: Feld, O, et al.
Publicado: (2013)

Newer treatments for decompensated heart failure: focus on levosimendan
por: Follath, Ferenc
Publicado: (2009)

Cardiac output estimation with transesophageal Doppler
por: Donati, A, et al.
Publicado: (1998)

Can clinicians reliably estimate cardiac output in children?
por: Tibby, S, et al.
Publicado: (1997)

Monitoring of intrathoracic volumes in induced supranormal cardiac output
por: Kerner, T, et al.
Publicado: (2002)

Measurement of aortal blood flow in supranormal cardiac output
por: Kerner, T, et al.
Publicado: (1999)

Effects of levosimendan/furosemide infusion on Plasma Brain Natriuretic Peptide, echocardiographic parameters and cardiac output in end-stage heart failure patients
por: Feola, Mauro, et al.
Publicado: (2011)

Biocompatible membranes in acute renal failure (ARF), hope or illusion?
por: Gašparovic, V, et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_9esibksvmejdg60dalsrnbfgsl